Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
Leukemia & Lymphoma|July 19, 2017
Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval lengthEric M Ammann, Tait D Shanafelt, Kara B Wright, et al.Clinical Lymphoma, Myeloma & Leukemia|August 14, 2017
Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaEric M Ammann, Tait D Shanafelt, Melissa C Larson, et al.Medical Care|October 25, 2007
Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methodsJohn M Brooks, Elizabeth A ChrischillesBlood|October 8, 2015
Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancyEric M Ammann, Michael P Jones, Brian K Link, et al.Medicine|February 22, 2018
Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed DatabaseEric M Ammann, Adam Cuker, Ryan M Carnahan, et al.American Journal of Epidemiology|April 19, 2012
Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indicationGang Fang, John M Brooks, Elizabeth A ChrischillesMedical Care|July 9, 2010
A new method to isolate local-area practice styles in prescription use as the basis for instrumental variables in comparative effectiveness researchGang Fang, John M Brooks, Elizabeth A ChrischillesAmerican Journal of Epidemiology|November 17, 2011
Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational dataGang Fang, John M Brooks, Elizabeth A ChrischillesAmerican Journal of Hematology|March 15, 2016
Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTsEric M Ammann, Cole B Haskins, Kelsey M Fillman, et al.Leukemia Research|May 1, 2026
Assessing the value of measuring frailty in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaVanessa E Slater, Bradley D McDowell, Elizabeth A ChrischillesPageof 20